Akkermansia muciniphila: biology, microbial ecology, host interactions and therapeutic potential.
Journal
Nature reviews. Microbiology
ISSN: 1740-1534
Titre abrégé: Nat Rev Microbiol
Pays: England
ID NLM: 101190261
Informations de publication
Date de publication:
15 Oct 2024
15 Oct 2024
Historique:
accepted:
02
09
2024
medline:
16
10
2024
pubmed:
16
10
2024
entrez:
15
10
2024
Statut:
aheadofprint
Résumé
Akkermansia muciniphila is a gut bacterium that colonizes the gut mucosa, has a role in maintaining gut health and shows promise for potential therapeutic applications. The discovery of A. muciniphila as an important member of our gut microbiome, occupying an extraordinary niche in the human gut, has led to new hypotheses on gut health, beneficial microorganisms and host-microbiota interactions. This microorganism has established a unique position in human microbiome research, similar to its role in the gut ecosystem. Its unique traits in using mucin sugars and mechanisms of action that can modify host health have made A. muciniphila a subject of enormous attention from multiple research fields. A. muciniphila is becoming a model organism studied for its ability to modulate human health and gut microbiome structure, leading to commercial products, a genetic model and possible probiotic formulations. This Review provides an overview of A. muciniphila and Akkermansia genus phylogeny, ecophysiology and diversity. Furthermore, the Review discusses perspectives on ecology, strategies for harnessing beneficial effects of A. muciniphila for human mucosal metabolic and gut health, and its potential as a biomarker for diagnostics and prognostics.
Identifiants
pubmed: 39406893
doi: 10.1038/s41579-024-01106-1
pii: 10.1038/s41579-024-01106-1
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Springer Nature Limited.
Références
Matijašić, M. et al. Gut microbiota beyond bacteria—mycobiome, virome, archaeome, and eukaryotic parasites in IBD. Int. J. Mol. Sci. 21, 2668 (2020).
pubmed: 32290414
pmcid: 7215374
doi: 10.3390/ijms21082668
Sender, R., Fuchs, S. & Milo, R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14, e1002533 (2016).
pubmed: 27541692
pmcid: 4991899
doi: 10.1371/journal.pbio.1002533
Davenport, E. R. et al. The human microbiome in evolution. BMC Biol. 15, 127 (2017).
pubmed: 29282061
pmcid: 5744394
doi: 10.1186/s12915-017-0454-7
Goodrich, J. K. et al. Human genetics shape the gut microbiome. Cell 159, 789–799 (2014).
pubmed: 25417156
pmcid: 4255478
doi: 10.1016/j.cell.2014.09.053
Lange, K., Buerger, M., Stallmach, A. & Bruns, T. Effects of antibiotics on gut microbiota. Dig. Dis. 34, 260–268 (2016).
pubmed: 27028893
doi: 10.1159/000443360
Bokulich, N. A. et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci. Transl. Med. 8, 343ra82 (2016).
pubmed: 27306664
pmcid: 5308924
doi: 10.1126/scitranslmed.aad7121
Perler, B. K., Friedman, E. S. & Wu, G. D. The role of the gut microbiota in the relationship between diet and human health. Annu. Rev. Physiol. 85, 449–468 (2023).
pubmed: 36375468
doi: 10.1146/annurev-physiol-031522-092054
Adak, A. & Khan, M. R. An insight into gut microbiota and its functionalities. Cell. Mol. Life Sci. 76, 473–493 (2019).
pubmed: 30317530
doi: 10.1007/s00018-018-2943-4
Jandhyala, S. M. et al. Role of the normal gut microbiota. World J. Gastroenterol. 21, 8836–8847 (2015).
doi: 10.3748/wjg.v21.i29.8787
Haneishi, Y. et al. Inflammatory bowel diseases and gut microbiota. Int. J. Mol. Sci. 24, 3817 (2023).
pubmed: 36835245
pmcid: 9958622
doi: 10.3390/ijms24043817
Christovich, A. & Luo, X. M. Gut microbiota, leaky gut, and autoimmune diseases. Front. Immunol. 13, 946248 (2022).
pubmed: 35833129
pmcid: 9271567
doi: 10.3389/fimmu.2022.946248
Wang, P. X., Deng, X. R., Zhang, C. H. & Yuan, H. J. Gut microbiota and metabolic syndrome. Chin. Med. J. 133, 808–816 (2020).
pubmed: 32106124
pmcid: 7147654
doi: 10.1097/CM9.0000000000000696
Bagheri, Z., Moeinzadeh, L. & Razmkhah, M. Roles of microbiota in cancer: from tumor development to treatment. J. Oncol. 2022, 3845104 (2022).
pubmed: 35342407
pmcid: 8941494
doi: 10.1155/2022/3845104
Akagawa, S. & Kaneko, K. Gut microbiota and allergic diseases in children. Allergol. Int. 71, 301–309 (2022).
pubmed: 35314107
doi: 10.1016/j.alit.2022.02.004
Sorboni, S. G., Moghaddam, H. S., Jafarzadeh-Esfehani, R. & Soleimanpour, S. A comprehensive review on the role of the gut microbiome in human neurological disorders. Clin. Microbiol. Rev. 35, e0033820 (2022).
pubmed: 34985325
doi: 10.1128/CMR.00338-20
Maciel-Fiuza, M. F. et al. Role of gut microbiota in infectious and inflammatory diseases. Front. Microbiol. 14, 1098386 (2023).
pubmed: 37051522
pmcid: 10083300
doi: 10.3389/fmicb.2023.1098386
Derrien, M., Vaughan, E. E., Plugge, C. M. & de Vos, W. M. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol. 54, 1469–1476 (2004). This paper describes the discovery and basic characterization of A. muciniphila.
pubmed: 15388697
doi: 10.1099/ijs.0.02873-0
van Passel, M. W. J. et al. The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS ONE 6, e16876 (2011).
pubmed: 21390229
pmcid: 3048395
doi: 10.1371/journal.pone.0016876
Derrien, M. et al. Mucin–bacterial interactions in the human oral cavity and digestive tract. Gut Microbes 1, 254–268 (2010).
pubmed: 21327032
pmcid: 3023607
doi: 10.4161/gmic.1.4.12778
Belzer, C. et al. Microbial metabolic networks at the mucus layer lead to diet-independent butyrate and vitamin B
doi: 10.1128/mBio.00770-17
Ottman, N., Geerlings, S. Y., Aalvink, S., de Vos, W. M. & Belzer, C. Action and function of Akkermansia muciniphila in microbiome ecology, health and disease. Best. Pract. Res. Clin. Gastroenterol. 31, 637–642 (2017).
pubmed: 29566906
doi: 10.1016/j.bpg.2017.10.001
Everard, A. et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl Acad. Sci. USA 110, 9066–9071 (2013). This mouse study provides insights into the role of A. muciniphila in the context of obesity and type 2 diabetes.
pubmed: 23671105
pmcid: 3670398
doi: 10.1073/pnas.1219451110
Chelakkot, C. et al. Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp. Mol. Med. 50, e450 (2018).
pubmed: 29472701
pmcid: 5903829
doi: 10.1038/emm.2017.282
Van Der Lugt, B. et al. Akkermansia muciniphila ameliorates the age-related decline in colonic mucus thickness and attenuates immune activation in accelerated aging Ercc1
Cani, P. D., Depommier, C., Derrien, M., Everard, A. & de Vos, W. M. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat. Rev. Gastroenterol. Hepatol. 19, 625–637 (2022).
pubmed: 35641786
doi: 10.1038/s41575-022-00631-9
Ley, R. E. et al. Evolution of mammals and their gut microbes. Science 320, 1647–1651 (2008).
pubmed: 18497261
pmcid: 2649005
doi: 10.1126/science.1155725
Sommer, F. et al. The gut microbiota modulates energy metabolism in the hibernating brown bear Ursus arctos. Cell Rep. 14, 1655–1661 (2016).
pubmed: 26854221
doi: 10.1016/j.celrep.2016.01.026
Carey, H. V., Walters, W. A. & Knight, R. Seasonal restructuring of the ground squirrel gut microbiota over the annual hibernation cycle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304, R33–R42 (2013).
pubmed: 23152108
doi: 10.1152/ajpregu.00387.2012
Sonoyama, K. et al. Response of gut microbiota to fasting and hibernation in Syrian hamsters. Appl. Env. Microbiol. 75, 6451–6456 (2009).
doi: 10.1128/AEM.00692-09
Costello, E. K., Gordon, J. I., Secor, S. M. & Knight, R. Postprandial remodeling of the gut microbiota in Burmese pythons. ISME J. 4, 1375–1385 (2010).
pubmed: 20520652
doi: 10.1038/ismej.2010.71
Ouwerkerk, J. P. et al. Adaptation of Akkermansia muciniphila to the oxic–anoxic interface of the mucus layer. Appl. Env. Microbiol. 82, 6983–6993 (2016). This work shows the unique adaptation of A. muciniphila to the oxygen gradient of the mucus layer.
doi: 10.1128/AEM.01641-16
Belzer, C. & de Vos, W. M. Microbes inside—from diversity to function: the case of Akkermansia. ISME J. 6, 1449–1458 (2012).
pubmed: 22437156
pmcid: 3401025
doi: 10.1038/ismej.2012.6
Green, T. J., Smullen, R. & Barnes, A. C. Dietary soybean protein concentrate-induced intestinal disorder in marine farmed Atlantic salmon, Salmo salar is associated with alterations in gut microbiota. Vet. Microbiol. 166, 286–292 (2013).
pubmed: 23810699
doi: 10.1016/j.vetmic.2013.05.009
Derrien, M., Collado, M. C., Ben-Amor, K., Salminen, S. & De Vos, W. M. The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl. Env. Microbiol. 74, 1646–1648 (2008).
doi: 10.1128/AEM.01226-07
Karcher, N. et al. Genomic diversity and ecology of human-associated Akkermansia species in the gut microbiome revealed by extensive metagenomic assembly. Genome Biol. 22, 1–24 (2021). This research describes a large-scale population genomics dataset of the genus Akkermansia and reveals a large phylogenetic and functional diversity of this genus.
doi: 10.1186/s13059-021-02427-7
Collado, M. C., Derrien, M., Isolauri, E., De Vos, W. M. & Salminen, S. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl. Env. Microbiol. 73, 7767–7770 (2007).
doi: 10.1128/AEM.01477-07
Guo, X. et al. Different subtype strains of Akkermansia muciniphila abundantly colonize in southern China. J. Appl. Microbiol. 120, 452–459 (2016).
pubmed: 26666632
pmcid: 4736461
doi: 10.1111/jam.13022
Geerlings, S. Y., Kostopoulos, I., de Vos, W. M. & Belzer, C. Akkermansia muciniphila in the human gastrointestinal tract: when, where, and how? Microorganisms 6, 75 (2018).
pubmed: 30041463
pmcid: 6163243
doi: 10.3390/microorganisms6030075
Momozawa, Y., Deffontaine, V., Louis, E. & Medrano, J. F. Characterization of bacteria in biopsies of colon and stools by high throughput sequencing of the V2 region of bacterial 16S rRNA gene in human. PLoS ONE 6, e16952 (2011).
pubmed: 21347324
pmcid: 3037395
doi: 10.1371/journal.pone.0016952
Nayfach, S., Shi, Z. J., Seshadri, R., Pollard, K. S. & Kyrpides, N. C. New insights from uncultivated genomes of the global human gut microbiome. Nature 568, 505–510 (2019).
pubmed: 30867587
pmcid: 6784871
doi: 10.1038/s41586-019-1058-x
Palmas, V. et al. Gut microbiota markers and dietary habits associated with extreme longevity in healthy Sardinian centenarians. Nutrients 14, 2436 (2022).
pubmed: 35745166
pmcid: 9227524
doi: 10.3390/nu14122436
Biagi, E. et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE 5, e10667 (2010).
pubmed: 20498852
pmcid: 2871786
doi: 10.1371/journal.pone.0010667
Biagi, E. et al. Gut microbiota and extreme longevity. Curr. Biol. 26, 1480–1485 (2016).
pubmed: 27185560
doi: 10.1016/j.cub.2016.04.016
Wu, L. et al. Gut microbiota as an antioxidant system in centenarians associated with high antioxidant activities of gut-resident Lactobacillus. NPJ Biofilms Microbiomes 8, 102 (2022).
pubmed: 36564415
pmcid: 9789086
doi: 10.1038/s41522-022-00366-0
Kim, B.-S. et al. Comparison of the gut microbiota of centenarians in longevity villages of South Korea with those of other age groups. J. Microbiol. Biotechnol. 29, 429–440 (2019).
pubmed: 30661321
doi: 10.4014/jmb.1811.11023
Wang, F. et al. Gut microbiota community and its assembly associated with age and diet in Chinese centenarians. J. Microbiol. Biotechnol. 25, 1195–1204 (2015).
pubmed: 25839332
doi: 10.4014/jmb.1410.10014
Cătoi, A. F. et al. Gut microbiota and aging—a focus on centenarians. Biochim. Biophys. Acta, Mol. Cell Res. 1866, 165765 (2020).
doi: 10.1016/j.bbadis.2020.165765
Lv, Q.-B. et al. A thousand metagenome-assembled genomes of Akkermansia reveal phylogroups and geographical and functional variations in the human gut. Front. Cell Infect. Microbiol. 12, 957439 (2022).
pubmed: 35982777
pmcid: 9378777
doi: 10.3389/fcimb.2022.957439
Daniel, N., Gewirtz, A. T. & Chassaing, B. Akkermansia muciniphila counteracts the deleterious effects of dietary emulsifiers on microbiota and host metabolism. Gut 72, 906–917 (2023).
pubmed: 36646449
doi: 10.1136/gutjnl-2021-326835
Guo, X. et al. Genome sequencing of 39 Akkermansia muciniphila isolates reveals its population structure, genomic and functional diversity, and global distribution in mammalian gut microbiotas. BMC Genomics 18, 800 (2017).
pubmed: 29047329
pmcid: 5648452
doi: 10.1186/s12864-017-4195-3
González, D., Morales-Olavarria, M., Vidal-Veuthey, B. & Cárdenas, J. P. Insights into early evolutionary adaptations of the Akkermansia genus to the vertebrate gut. Front. Microbiol. 14, 1238580 (2023). This paper reports the genomic potential of Akkermansia spp. in relation to environmental conditions that have led to traits important for colonization of the gut.
pubmed: 37779688
pmcid: 10540074
doi: 10.3389/fmicb.2023.1238580
Kumar, R. et al. Identification and characterization of a novel species of genus Akkermansia with metabolic health effects in a diet-induced obesity mouse model. Cells 11, 2084 (2022).
pubmed: 35805168
pmcid: 9265676
doi: 10.3390/cells11132084
Truong, D. T., Tett, A., Pasolli, E., Huttenhower, C. & Segata, N. Microbial strain-level population structure and genetic diversity from metagenomes. Genome Res. 27, 626–638 (2017).
pubmed: 28167665
pmcid: 5378180
doi: 10.1101/gr.216242.116
Geerlings, S. Y. et al. Genomic convergence between Akkermansia muciniphila in different mammalian hosts. BMC Microbiol. 21, 298 (2021).
pubmed: 34715771
pmcid: 8555344
doi: 10.1186/s12866-021-02360-6
Luna, E. et al. Utilization efficiency of human milk oligosaccharides by human-associated Akkermansia is strain dependent. Appl. Env. Microbiol. 88, e0148721 (2022).
doi: 10.1128/AEM.01487-21
Ouwerkerk, J. P., Aalvink, S., Belzer, C. & de Vos, W. M. Akkermansia glycaniphila sp. nov., an anaerobic mucin-degrading bacterium isolated from reticulated python faeces. Int. J. Syst. Evol. Microbiol. 66, 4614–4620 (2016).
pubmed: 27499019
doi: 10.1099/ijsem.0.001399
Ndongo, S., Armstrong, N., Raoult, D. & Fournier, P. E. Reclassification of eight Akkermansia muciniphila strains and description of Akkermansia massiliensis sp. nov. and Candidatus Akkermansia timonensis, isolated from human feces. Sci. Rep. 12, 21747 (2022).
pubmed: 36526682
pmcid: 9758162
doi: 10.1038/s41598-022-25873-0
Liu, Q. et al. Akkermansia muciniphila exerts strain-specific effects on DSS-induced ulcerative colitis in mice. Front. Cell Infect. Microbiol. 11, 698914 (2021).
pubmed: 34422681
pmcid: 8371549
doi: 10.3389/fcimb.2021.698914
Kirmiz, N. et al. Comparative genomics guides elucidation of Vitamin B
doi: 10.1128/AEM.02117-19
Zhai, R. et al. Strain-specific anti-inflammatory properties of two Akkermansia muciniphila strains on chronic colitis in mice. Front. Cell Infect. Microbiol. 9, 239 (2019).
pubmed: 31334133
pmcid: 6624636
doi: 10.3389/fcimb.2019.00239
Ottman, N. et al. Characterization of outer membrane proteome of Akkermansia muciniphila reveals sets of novel proteins exposed to the human intestine. Front. Microbiol. 7, 1157 (2016).
pubmed: 27507967
pmcid: 4960237
doi: 10.3389/fmicb.2016.01157
Ligthart, K., Belzer, C., de Vos, W. M. & Tytgat, H. L. P. Bridging bacteria and the gut: functional aspects of type IV pili. Trends Microbiol. 28, 340–348 (2020).
pubmed: 32298612
doi: 10.1016/j.tim.2020.02.003
Ottman, N. et al. Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function. PLoS ONE 12, 1–18 (2017). This study discovers the pili-like protein Amuc_1100, and describes its effect on host immune response and gut barrier function.
doi: 10.1371/journal.pone.0173004
Xiang, R., Wang, J., Xu, W., Zhang, M. & Wang, M. Amuc_1102 from Akkermansia muciniphila adopts an immunoglobulin-like fold related to archaeal type IV pilus. Biochem. Biophys. Res. Commun. 547, 59–64 (2021).
pubmed: 33592380
doi: 10.1016/j.bbrc.2021.02.022
Reunanen, J. et al. Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer. Appl. Env. Microbiol. 81, 3655–3662 (2015). This paper shows that A. muciniphila adheres to human colonic cell lines and increases cell layer integrity.
doi: 10.1128/AEM.04050-14
Elzinga, J. et al. Binding of Akkermansia muciniphila to mucin is O-glycan specific. Nat. Commun. 15, 4582 (2024).
pubmed: 38811534
pmcid: 11137150
doi: 10.1038/s41467-024-48770-8
Kostopoulos, I. et al. A continuous battle for host-derived glycans between a mucus specialist and a glycan generalist in vitro and in vivo. Front. Microbiol. 12, 1–14 (2021).
doi: 10.3389/fmicb.2021.632454
Garcia-Vello, P. et al. Peptidoglycan from Akkermansia muciniphila MucT: chemical structure and immunostimulatory properties of muropeptides. Glycobiology 32, 712–719 (2022).
pubmed: 35452117
doi: 10.1093/glycob/cwac027
van der Ark, K. C. H. et al. Model-driven design of a minimal medium for Akkermansia muciniphila confirms mucus adaptation. Microb. Biotechnol. 11, 476–485 (2018).
pubmed: 29377524
pmcid: 5902328
doi: 10.1111/1751-7915.13033
Ottman, N. et al. Genome-scale model and omics analysis of metabolic capacities of Akkermansia muciniphila reveal a preferential mucin-degrading lifestyle. Appl. Env. Microbiol. 83, e01014–e01017 (2017).
doi: 10.1128/AEM.01014-17
Parada Venegas, D. et al. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front. Immunol. 10, 277 (2019).
pubmed: 30915065
pmcid: 6421268
doi: 10.3389/fimmu.2019.00277
Hernández, M. A. G., Canfora, E. E., Jocken, J. W. E. & Blaak, E. E. The short-chain fatty acid acetate in body weight control and insulin sensitivity. Nutrients 11, 1943 (2019).
pubmed: 31426593
doi: 10.3390/nu11081943
Bridgeman, S. C. et al. Butyrate generated by gut microbiota and its therapeutic role in metabolic syndrome. Pharmacol. Res. 160, 105174 (2020).
pubmed: 32860943
doi: 10.1016/j.phrs.2020.105174
Hosseini, E., Grootaert, C., Verstraete, W. & Van de Wiele, T. Propionate as a health-promoting microbial metabolite in the human gut. Nutr. Rev. 69, 245–258 (2011).
pubmed: 21521227
doi: 10.1111/j.1753-4887.2011.00388.x
De Vadder, F. et al. Microbiota-generated metabolites promote metabolic benefits via gut–brain neural circuits. Cell 156, 84–96 (2014).
pubmed: 24412651
doi: 10.1016/j.cell.2013.12.016
Corfield, A. P., Wagner, S. A., Clamp, J. R., Kriaris, M. S. & Hoskins, L. C. Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria. Infect. Immun. 60, 3971–3978 (1992).
pubmed: 1398908
pmcid: 257425
doi: 10.1128/iai.60.10.3971-3978.1992
Tailford, L. E., Crost, E. H., Kavanaugh, D. & Juge, N. Mucin glycan foraging in the human gut microbiome. Front. Genet. 6, 81 (2015).
pubmed: 25852737
pmcid: 4365749
doi: 10.3389/fgene.2015.00081
Bakshani, C. R. et al. Carbohydrate-active enzymes from Akkermansia muciniphila. Preprint at bioRxiv https://doi.org/10.1101/2024.03.27.586211 (2024).
Huang, K. et al. Biochemical characterisation of the neuraminidase pool of the human gut symbiont Akkermansia muciniphila. Carbohydr. Res. 415, 60–65 (2015).
pubmed: 26340137
doi: 10.1016/j.carres.2015.08.001
Shuoker, B. et al. Sialidases and fucosidases of Akkermansia muciniphila are crucial for growth on mucin and nutrient sharing with mucus-associated gut bacteria. Nat. Commun. 14, 1833 (2023).
pubmed: 37005422
pmcid: 10067855
doi: 10.1038/s41467-023-37533-6
Kostopoulos, I. et al. Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro. Sci. Rep. 10, 14330 (2020).
pubmed: 32868839
pmcid: 7459334
doi: 10.1038/s41598-020-71113-8
Davey, L. E. et al. A genetic system for Akkermansia muciniphila reveals a role for mucin foraging in gut colonization and host sterol biosynthesis gene expression. Nat. Microbiol. 8, 1450–1467 (2023). This study reports a genetic system for A. muciniphila, applies transposon mutagenesis to A. muciniphila and gives insight into the importance of mucin-degrading enzymes for gut colonization.
pubmed: 37337046
doi: 10.1038/s41564-023-01407-w
Lee, J. Y. et al. Nutrient-specific proteomic analysis of the mucin degrading bacterium Akkermansia muciniphila. Proteomics 22, 2100125 (2022).
doi: 10.1002/pmic.202100125
Kosciow, K. & Deppenmeier, U. Characterization of three novel β-galactosidases from Akkermansia muciniphila involved in mucin degradation. Int. J. Biol. Macromol. 149, 331–340 (2020).
pubmed: 31991210
doi: 10.1016/j.ijbiomac.2020.01.246
Crouch, L. I. et al. Prominent members of the human gut microbiota express endo-acting O-glycanases to initiate mucin breakdown. Nat. Commun. 11, 4017 (2020).
pubmed: 32782292
pmcid: 7419316
doi: 10.1038/s41467-020-17847-5
Kosciow, K. & Deppenmeier, U. Characterization of a phospholipid-regulated β-galactosidase from Akkermansia muciniphila involved in mucin degradation. Microbiologyopen 8, 1–11 (2019).
doi: 10.1002/mbo3.796
Berkhout, M. D., Plugge, C. M. & Belzer, C. How microbial glycosyl hydrolase activity in the gut mucosa initiates microbial cross-feeding. Glycobiology 32, 182–200 (2022).
pubmed: 34939101
doi: 10.1093/glycob/cwab105
Ouwerkerk, J. P. et al. Comparative genomics and physiology of Akkermansia muciniphila isolates from human intestine reveal specialized mucosal adaptation. Microorganisms 10, 1605 (2022).
pubmed: 36014023
pmcid: 9415379
doi: 10.3390/microorganisms10081605
Belzer, C. Nutritional strategies for mucosal health: the interplay between microbes and mucin glycans. Trends Microbiol. 30, 13–21 (2021).
pubmed: 34217596
doi: 10.1016/j.tim.2021.06.003
Aakko, J. et al. Human milk oligosaccharide categories define the microbiota composition in human colostrum. Benef. Microbes 8, 563–567 (2017).
pubmed: 28726512
doi: 10.3920/BM2016.0185
Bäckhed, F. et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17, 690–703 (2015).
pubmed: 25974306
doi: 10.1016/j.chom.2015.04.004
Bergström, A. et al. Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants. Appl. Env. Microbiol. 80, 2889–2900 (2014).
doi: 10.1128/AEM.00342-14
Azad, M. B. et al. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ 185, 385–394 (2013).
pubmed: 23401405
pmcid: 3602254
doi: 10.1503/cmaj.121189
Grant, E. T., Boudaud, M., Muller, A., Macpherson, A. J. & Desai, M. S. Maternal diet and gut microbiome composition modulate early‐life immune development. EMBO Mol. Med. 15, e17241 (2023).
pubmed: 37278126
pmcid: 10405054
doi: 10.15252/emmm.202217241
Gurung, M. et al. Microbiota from human infants consuming secretors or non-secretors mothers’ milk impacts the gut and immune system in mice. mSystems 9, e0029424 (2024).
pubmed: 38530054
doi: 10.1128/msystems.00294-24
Padilla, L. et al. Mechanism of 2′-fucosyllactose degradation by human-associated Akkermansia. J. Bacteriol. 206, e0033423 (2024).
pubmed: 38299857
doi: 10.1128/jb.00334-23
Ribo, S. et al. Increasing breast milk betaine modulates Akkermansia abundance in mammalian neonates and improves long-term metabolic health. Sci. Transl. Med. 13, eabb0322 (2021).
pubmed: 33790021
pmcid: 8823629
doi: 10.1126/scitranslmed.abb0322
Meng, X. et al. A purified aspartic protease from Akkermansia muciniphila plays an important role in degrading Muc2. Int. J. Mol. Sci. 21, 72 (2021).
doi: 10.3390/ijms21010072
Shon, D. J., Fernandez, D., Riley, N. M., Ferracane, M. J. & Bertozzi, C. R. Structure-guided mutagenesis of a mucin-selective metalloprotease from Akkermansia muciniphila alters substrate preferences. J. Biol. Chem. 298, 101917 (2022).
pubmed: 35405095
pmcid: 9118916
doi: 10.1016/j.jbc.2022.101917
Shon, D. J. et al. An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins. Proc. Natl Acad. Sci. USA 117, 21299–21307 (2020).
pubmed: 32817557
pmcid: 7474620
doi: 10.1073/pnas.2012196117
Trastoy, B., Naegeli, A., Anso, I., Sjögren, J. & Guerin, M. E. Structural basis of mammalian mucin processing by the human gut O-glycopeptidase OgpA from Akkermansia muciniphila. Nat. Commun. 11, 4844 (2020). This paper characterizes the A. muciniphila O-glycopeptidase OgpA and describes its possible application to map O-glycosylation sites on a protein.
pubmed: 32973204
pmcid: 7518263
doi: 10.1038/s41467-020-18696-y
Medley, B. J. et al. A previously uncharacterized O-glycopeptidase from Akkermansia muciniphila requires the Tn-antigen for cleavage of the peptide bond. J. Biol. Chem. 298, 102439 (2022).
pubmed: 36049519
pmcid: 9513282
doi: 10.1016/j.jbc.2022.102439
Espey, M. G. Role of oxygen gradients in shaping redox relationships between the human intestine and its microbiota. Free. Radic. Biol. Med. 55, 130–140 (2013).
pubmed: 23127782
doi: 10.1016/j.freeradbiomed.2012.10.554
Machado, D. et al. Uncovering Akkermansia muciniphila resilience or susceptibility to different temperatures, atmospheres and gastrointestinal conditions. Anaerobe 61, 102135 (2020).
pubmed: 31875576
doi: 10.1016/j.anaerobe.2019.102135
Peña-Cearra, A. et al. Akkermansia muciniphila-induced trained immune phenotype increases bacterial intracellular survival and attenuates inflammation. Commun. Biol. 7, 192 (2024).
pubmed: 38365881
pmcid: 10873422
doi: 10.1038/s42003-024-05867-6
Dawson, P. A. & Karpen, S. J. Intestinal transport and metabolism of bile acids. J. Lipid Res. 56, 1085–1099 (2015).
pubmed: 25210150
pmcid: 4442867
doi: 10.1194/jlr.R054114
van der Ark, K. C. H. et al. Encapsulation of the therapeutic microbe Akkermansia muciniphila in a double emulsion enhances survival in simulated gastric conditions. Food Res. Int. 102, 372–379 (2017).
pubmed: 29195961
doi: 10.1016/j.foodres.2017.09.004
Hagi, T., Geerlings, S. Y., Nijsse, B. & Belzer, C. The effect of bile acids on the growth and global gene expression profiles in Akkermansia muciniphila. Appl. Microbiol. Biotechnol. 104, 10641–10653 (2020).
pubmed: 33159542
pmcid: 7671984
doi: 10.1007/s00253-020-10976-3
Juárez-Fernández, M. et al. The synbiotic combination of Akkermansia muciniphila and quercetin ameliorates early obesity and NAFLD through gut microbiota reshaping and bile acid metabolism modulation. Antioxidants 10, 2001 (2021).
pubmed: 34943104
pmcid: 8698339
doi: 10.3390/antiox10122001
Pierre, J. F. et al. Activation of bile acid signaling improves metabolic phenotypes in high-fat diet-induced obese mice. Am. J. Physiol. Gastrointest. Liver Physiol. 311, G286–G304 (2016).
pubmed: 27340128
pmcid: 5007288
doi: 10.1152/ajpgi.00202.2016
Ruas-Madiedo, P., Gueimonde, M., Arigoni, F., de los Reyes-Gavilán, C. G. & Margolles, A. Bile affects the synthesis of exopolysaccharides by Bifidobacterium animalis. Appl. Env. Microbiol. 75, 1204–1207 (2009).
doi: 10.1128/AEM.00908-08
Fanning, S. et al. Bifidobacterial surface-exopolysaccharide facilitates commensal–host interaction through immune modulation and pathogen protection. Proc. Natl Acad. Sci. USA 109, 2108–2113 (2012).
pubmed: 22308390
pmcid: 3277520
doi: 10.1073/pnas.1115621109
Anhê, F. F. et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut 64, 872–883 (2015).
pubmed: 25080446
doi: 10.1136/gutjnl-2014-307142
Roopchand, D. E. et al. Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high-fat diet-induced metabolic syndrome. Diabetes 64, 2847–2858 (2015).
pubmed: 25845659
pmcid: 4512228
doi: 10.2337/db14-1916
Salem, M. B., El-Lakkany, N. M., Seif el-Din, S. H., Hammam, O. A. & Samir, S. Diosmin alleviates ulcerative colitis in mice by increasing Akkermansia muciniphila abundance, improving intestinal barrier function, and modulating the NF-κB and Nrf2 pathways. Heliyon 10, e27527 (2024).
pubmed: 38500992
pmcid: 10945203
doi: 10.1016/j.heliyon.2024.e27527
Reider, S. et al. Short- and long-term effects of a prebiotic intervention with polyphenols extracted from European black elderberry—sustained expansion of Akkermansia spp. J. Pers. Med. 12, 1479 (2022).
pubmed: 36143265
pmcid: 9504334
doi: 10.3390/jpm12091479
Rodríguez-Daza, M. C. et al. Polyphenol-mediated gut microbiota modulation: toward prebiotics and further. Front. Nutr. 8, 689456 (2021).
pubmed: 34268328
pmcid: 8276758
doi: 10.3389/fnut.2021.689456
Rodríguez-Daza, M. C. & de Vos, W. M. Polyphenols as drivers of a homeostatic gut microecology and immuno-metabolic traits of Akkermansia muciniphila: from mouse to man. Int. J. Mol. Sci. 24, 45 (2022).
pubmed: 36613488
pmcid: 9820369
doi: 10.3390/ijms24010045
Van Buiten, C. B., Seitz, V. A., Metcalf, J. L. & Raskin, I. Dietary polyphenols support Akkermansia muciniphila growth via mediation of the gastrointestinal redox environment. Antioxidants 13, 304 (2024).
pubmed: 38539838
pmcid: 10967430
doi: 10.3390/antiox13030304
Rodríguez-Daza, M.-C. et al. Wild blueberry proanthocyanidins shape distinct gut microbiota profile and influence glucose homeostasis and intestinal phenotypes in high-fat high-sucrose fed mice. Sci. Rep. 10, 2217 (2020).
pubmed: 32041991
pmcid: 7010699
doi: 10.1038/s41598-020-58863-1
Lu, F. et al. Early-life polyphenol intake promotes Akkermansia growth and increase of host goblet cells in association with the potential synergistic effect of Lactobacillus. Food Res. Int. 149, 110648 (2021).
pubmed: 34600650
doi: 10.1016/j.foodres.2021.110648
Plovier, H. et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat. Med. 23, 107–113 (2016). This study shows that pasteurized A. muciniphila and purified Amuc_1100 induce beneficial metabolic effects in mice.
pubmed: 27892954
doi: 10.1038/nm.4236
Gao, X. et al. Akkermansia muciniphila-derived small extracellular vesicles attenuate intestinal ischemia–reperfusion-induced postoperative cognitive dysfunction by suppressing microglia activation via the TLR2/4 signaling. Biochim. Biophys. Acta, Mol. Cell Res. 1871, 119630 (2024).
pubmed: 37967793
doi: 10.1016/j.bbamcr.2023.119630
Kikkert, R., Laine, M. L., Aarden, L. A. & Van Winkelhoff, A. J. Activation of Toll‐like receptors 2 and 4 by Gram‐negative periodontal bacteria. Oral. Microbiol. Immunol. 22, 145–151 (2007).
pubmed: 17488439
doi: 10.1111/j.1399-302X.2007.00335.x
Mandell, L. et al. Intact Gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via Toll-like receptor 2 but not Toll-like receptor 4. Infect. Immun. 72, 6446–6454 (2004).
pubmed: 15501775
pmcid: 523003
doi: 10.1128/IAI.72.11.6446-6454.2004
Bae, M. et al. Akkermansia muciniphila phospholipid induces homeostatic immune responses. Nature 608, 168–173 (2022).
pubmed: 35896748
pmcid: 9328018
doi: 10.1038/s41586-022-04985-7
Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499–511 (2004).
pubmed: 15229469
doi: 10.1038/nri1391
Xie, S. et al. Novel tripeptide RKH derived from Akkermansia muciniphila protects against lethal sepsis. Gut 73, 78–91 (2024).
doi: 10.1136/gutjnl-2023-329996
Yoon, H. S. et al. Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice. Nat. Microbiol. 6, 563–573 (2021).
pubmed: 33820962
doi: 10.1038/s41564-021-00880-5
Kim, S.-M. et al. Secreted Akkermansia muciniphila threonyl-tRNA synthetase functions to monitor and modulate immune homeostasis. Cell Host Microbe 31, 1021–1037 (2023).
pubmed: 37269833
doi: 10.1016/j.chom.2023.05.007
Zhang, Q. et al. Genetic mapping of microbial and host traits reveals production of immunomodulatory lipids by Akkermansia muciniphila in the murine gut. Nat. Microbiol. 8, 424–440 (2023).
pubmed: 36759753
pmcid: 9981464
doi: 10.1038/s41564-023-01366-2
Seck, E. H. et al. Salt in stools is associated with obesity, gut halophilic microbiota and Akkermansia muciniphila depletion in humans. Int. J. Obes. 43, 862–871 (2019).
doi: 10.1038/s41366-018-0201-3
Dao, M. C. et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65, 426–436 (2016).
pubmed: 26100928
doi: 10.1136/gutjnl-2014-308778
Santacruz, A. et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br. J. Nutr. 104, 83–92 (2010).
pubmed: 20205964
doi: 10.1017/S0007114510000176
Dao, X. M. C. et al. Akkermansia muciniphila abundance is lower in severe obesity, but its increased level after bariatric surgery is not associated with metabolic health improvement. Am. J. Physiol. Endocrinol. Metab. 317, E446–E459 (2019).
pubmed: 31265324
doi: 10.1152/ajpendo.00140.2019
Ouwerkerk, J. P., De Vos, W. M. & Belzer, C. Glycobiome: bacteria and mucus at the epithelial interface. Best. Pract. Res. Clin. Gastroenterol. 27, 25–38 (2013).
pubmed: 23768550
doi: 10.1016/j.bpg.2013.03.001
Schneeberger, M. et al. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci. Rep. 5, 16643 (2015).
pubmed: 26563823
pmcid: 4643218
doi: 10.1038/srep16643
Zhang, J. et al. Decreased abundance of Akkermansia muciniphila leads to the impairment of insulin secretion and glucose homeostasis in lean type 2 diabetes. Adv. Sci. 8, 2100536 (2021).
doi: 10.1002/advs.202100536
Shin, N. R. et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63, 727–735 (2014).
pubmed: 23804561
doi: 10.1136/gutjnl-2012-303839
Zhao, S. et al. Akkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed mice. J. Mol. Endocrinol. 58, 1–14 (2017).
pubmed: 27821438
doi: 10.1530/JME-16-0054
Wu, F. et al. An Akkermansia muciniphila subtype alleviates high-fat diet-induced metabolic disorders and inhibits the neurodegenerative process in mice. Anaerobe 61, 102138 (2020).
pubmed: 31830598
doi: 10.1016/j.anaerobe.2019.102138
Kim, S. et al. Akkermansia muciniphila prevents fatty liver disease, decreases serum triglycerides, and maintains gut homeostasis. Appl. Env. Microbiol. 86, e03004–e03019 (2020).
doi: 10.1128/AEM.03004-19
Depommier, C. et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat. Med. 25, 1096–1103 (2019). This study shows that pasteurized A. muciniphila is safe and tolerated by human subjects.
pubmed: 31263284
pmcid: 6699990
doi: 10.1038/s41591-019-0495-2
Lukovac, S. et al. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. mBio 5, e01438–14 (2014).
pubmed: 25118238
pmcid: 4145684
doi: 10.1128/mBio.01438-14
McLoughlin, R. M. et al. Interplay between IFN-γ and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J. Clin. Investig. 112, 598 (2003).
pubmed: 12925700
pmcid: 171385
doi: 10.1172/JCI17129
Greer, R. L. et al. Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism. Nat. Commun. 7, 1–13 (2016).
doi: 10.1038/ncomms13329
Davenport, E. R. et al. Genome-wide association studies of the human gut microbiota. PLoS ONE 10, e0140301 (2015).
pubmed: 26528553
pmcid: 4631601
doi: 10.1371/journal.pone.0140301
Viera, J. T., El-Merahbi, R., Nieswandt, B., Stegner, D. & Sumara, G. Phospholipases D
doi: 10.1371/journal.pone.0157607
Alberts, A. et al. Binding of macrophage receptor MARCO, LDL, and LDLR to disease-associated crystalline structures. Front. Immunol. 11, 596103 (2020).
pubmed: 33363539
pmcid: 7753766
doi: 10.3389/fimmu.2020.596103
Ansaldo, E. et al. Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis. Science 364, 1179–1184 (2019).
pubmed: 31221858
pmcid: 6645389
doi: 10.1126/science.aaw7479
Wu, W. et al. Protective effect of Akkermansia muciniphila against immune-mediated liver injury in a mouse model. Front. Microbiol. 8, 1804 (2017).
pubmed: 29033903
pmcid: 5626943
doi: 10.3389/fmicb.2017.01804
Kim, S. et al. Mucin degrader Akkermansia muciniphila accelerates intestinal stem cell-mediated epithelial development. Gut Microbes 13, 1892441 (2021).
pubmed: 33678130
pmcid: 7946046
doi: 10.1080/19490976.2021.1892441
Wang, L. et al. A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8
pubmed: 32169907
doi: 10.1136/gutjnl-2019-320105
Kang, C. S. et al. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS ONE 8, e76520 (2013).
pubmed: 24204633
pmcid: 3811976
doi: 10.1371/journal.pone.0076520
Earley, H. et al. The abundance of Akkermansia muciniphila and its relationship with sulphated colonic mucins in health and ulcerative colitis. Sci. Rep. 9, 15683 (2019).
pubmed: 31666581
pmcid: 6821857
doi: 10.1038/s41598-019-51878-3
Kang, E.-J. et al. The secreted protein Amuc_1409 from Akkermansia muciniphila improves gut health through intestinal stem cell regulation. Nat. Commun. 15, 2983 (2024).
pubmed: 38582860
pmcid: 10998920
doi: 10.1038/s41467-024-47275-8
Podolsky, D. K., Gerken, G., Eyking, A. & Cario, E. Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency. Gastroenterology 137, 209–220 (2009).
pubmed: 19303021
doi: 10.1053/j.gastro.2009.03.007
Cario, E., Gerken, G. & Podolsky, D. K. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132, 1359–1374 (2007).
pubmed: 17408640
doi: 10.1053/j.gastro.2007.02.056
Desai, M. S. et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167, 1339–1353 (2016).
pubmed: 27863247
pmcid: 5131798
doi: 10.1016/j.cell.2016.10.043
Kuffa, P. et al. Fiber-deficient diet inhibits colitis through the regulation of the niche and metabolism of a gut pathobiont. Cell Host Microbe 31, 2007–2022 (2023).
pubmed: 37967555
doi: 10.1016/j.chom.2023.10.016
Parrish, A. et al. Akkermansia muciniphila exacerbates food allergy in fibre-deprived mice. Nat. Microbiol. 8, 1863–1879 (2023).
pubmed: 37696941
pmcid: 10522492
doi: 10.1038/s41564-023-01464-1
Wolter, M. et al. Diet-driven differential response of Akkermansia muciniphila modulates pathogen susceptibility. Mol. Syst. Biol. 20, 596–625 (2024).
pubmed: 38745106
pmcid: 11148096
doi: 10.1038/s44320-024-00036-7
Shono, Y. et al. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci. Transl. Med. 8, 339ra71 (2016).
pubmed: 27194729
pmcid: 4991773
doi: 10.1126/scitranslmed.aaf2311
Konstanti, P. et al. Physiology of γ-aminobutyric acid production by Akkermansia muciniphila. Appl. Env. Microbiol. 90, e0112123 (2024).
doi: 10.1128/aem.01121-23
Yunes, R. A. et al. GABA production and structure of gadB/gadC genes in Lactobacillus and Bifidobacterium strains from human microbiota. Anaerobe 42, 197–204 (2016).
pubmed: 27794467
doi: 10.1016/j.anaerobe.2016.10.011
Olson, C. A. et al. The gut microbiota mediates the anti-seizure effects of the ketogenic diet. Cell 173, 1728–1741 (2018).
pubmed: 29804833
pmcid: 6003870
doi: 10.1016/j.cell.2018.04.027
Li, Z. et al. Multi-omics analyses of serum metabolome, gut microbiome and brain function reveal dysregulated microbiota–gut–brain axis in bipolar depression. Mol. Psychiatry 27, 4123–4135 (2022).
pubmed: 35444255
doi: 10.1038/s41380-022-01569-9
Xi, W. et al. Depicting the composition of gut microbiota in children with tic disorders: an exploratory study. J. Child. Psychol. Psychiatry 62, 1246–1254 (2021).
pubmed: 33738808
doi: 10.1111/jcpp.13409
Fang, X., Li, F. J. & Hong, D. J. Potential role of Akkermansia muciniphila in Parkinson’s disease and other neurological/autoimmune diseases. Curr. Med. Sci. 41, 1172–1177 (2021).
pubmed: 34893951
doi: 10.1007/s11596-021-2464-5
Cox, L. M. et al. The gut microbiome in progressive multiple sclerosis. Ann. Neurol. 89, 1195–1211 (2021).
pubmed: 33876477
pmcid: 8132291
doi: 10.1002/ana.26084
Blacher, E. et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature 572, 474–480 (2019).
pubmed: 31330533
doi: 10.1038/s41586-019-1443-5
Chia, L. W. et al. Deciphering the trophic interaction between Akkermansia muciniphila and the butyrogenic gut commensal Anaerostipes caccae using a metatranscriptomic approach. Antonie Van. Leeuwenhoek 111, 859–873 (2018).
pubmed: 29460206
pmcid: 5945754
doi: 10.1007/s10482-018-1040-x
Pichler, M. J. et al. Butyrate producing colonic clostridiales metabolise human milk oligosaccharides and cross feed on mucin via conserved pathways. Nat. Commun. 11, 3285 (2020).
pubmed: 32620774
pmcid: 7335108
doi: 10.1038/s41467-020-17075-x
Shetty, S. A. et al. Dynamic metabolic interactions and trophic roles of human gut microbes identified using a minimal microbiome exhibiting ecological properties. ISME J. 16, 2144–2159 (2022).
pubmed: 35717467
pmcid: 9381525
doi: 10.1038/s41396-022-01255-2
Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174–180 (2011).
pubmed: 21508958
pmcid: 3728647
doi: 10.1038/nature09944
Derrien, M., Belzer, C. & de Vos, W. M. Akkermansia muciniphila and its role in regulating host functions. Microb. Pathog. 106, 171–181 (2017).
pubmed: 26875998
doi: 10.1016/j.micpath.2016.02.005
Rasmussen, T. S. et al. Fecal virome transfer improves proliferation of commensal gut Akkermansia muciniphila and unexpectedly enhances the fertility rate in laboratory mice. Gut Microbes 15, 2208504 (2023).
pubmed: 37150906
pmcid: 10167882
doi: 10.1080/19490976.2023.2208504
Yang, W., Ao, M., Hu, Y., Li, Q. K. & Zhang, H. Mapping the O‐glycoproteome using site‐specific extraction of O‐linked glycopeptides (EXoO). Mol. Syst. Biol. 14, e8486 (2018).
pubmed: 30459171
pmcid: 6243375
doi: 10.15252/msb.20188486
Yang, S. et al. Deciphering protein O-glycosylation: solid-phase chemoenzymatic cleavage and enrichment. Anal. Chem. 90, 8261–8269 (2018).
pubmed: 29936827
doi: 10.1021/acs.analchem.8b01834
King, S. L. et al. Characterizing the O-glycosylation landscape of human plasma, platelets, and endothelial cells. Blood Adv. 1, 429–442 (2017).
pubmed: 29296958
pmcid: 5738978
doi: 10.1182/bloodadvances.2016002121
Ma, C. et al. Comprehensive N- and O-glycosylation mapping of human coagulation factor V. J. Thromb. Haemost. 18, 1884–1892 (2020).
pubmed: 32310329
pmcid: 7732234
doi: 10.1111/jth.14861
Lombard, V., Golaconda Ramulu, H., Drula, E., Coutinho, P. M. & Henrissat, B. The carbohydrate-active enzymes database (CAZy) in 2013. Nucleic Acids Res. 42, 490–495 (2014).
doi: 10.1093/nar/gkt1178
Turck, D. et al. Safety of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015/2283. EFSA J. 19, e06780 (2021).
pubmed: 34484452
pmcid: 8409316
Yang, J. et al. Disparate metabolic responses in mice fed a high-fat diet supplemented with maize-derived non-digestible feruloylated oligo and polysaccharides are linked to changes in the gut microbiota. PLoS ONE 11, e0146144 (2016).
pubmed: 26731528
pmcid: 4701460
doi: 10.1371/journal.pone.0146144
Song, H. et al. Red pitaya betacyanins protects from diet-induced obesity, liver steatosiaand insulin resistance in association with modulation of gut microbiota in mice. J. Gastroenterol. Hepatol. 31, 1462–1469 (2016).
pubmed: 26699443
doi: 10.1111/jgh.13278
Gómez-Gallego, C. et al. Infant formula supplemented with polyamines alters the intestinal microbiota in neonatal BALB/cOlaHsd mice. J. Nutr. Biochem. 23, 1508–1513 (2012).
pubmed: 22402370
doi: 10.1016/j.jnutbio.2011.10.003
Andersson, K. E. et al. Diverse effects of oats on cholesterol metabolism in C57BL/6 mice correlate with expression of hepatic bile acid-producing enzymes. Eur. J. Nutr. 52, 1755–1769 (2013).
pubmed: 23262749
doi: 10.1007/s00394-012-0479-1
Everard, A. et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60, 2775–2786 (2011).
pubmed: 21933985
pmcid: 3198091
doi: 10.2337/db11-0227
Li, L. et al. Function and therapeutic prospects of next-generation probiotic Akkermansia muciniphila in infectious diseases. Front. Microbiol. 15, 1354447 (2024).
pubmed: 38384263
pmcid: 10880487
doi: 10.3389/fmicb.2024.1354447
Jia, B., Zou, Y., Han, X., Bae, J.-W. & Jeon, C. O. Gut microbiome-mediated mechanisms for reducing cholesterol levels: implications for ameliorating cardiovascular disease. Trends Microbiol. 31, 76–91 (2023).
pubmed: 36008191
doi: 10.1016/j.tim.2022.08.003
Hasani, A. et al. The role of Akkermansia muciniphila in obesity, diabetes and atherosclerosis. J. Med. Microbiol. 70, 001435 (2021).
doi: 10.1099/jmm.0.001435
Wang, L. & Tang, D. Akkermania muciniphila: a rising star in tumor immunology. Clin. Transl. Oncol. https://doi.org/10.1007/s12094-024-03493-6 (2024).
Pellegrino, A., Coppola, G., Santopaolo, F., Gasbarrini, A. & Ponziani, F. R. Role of Akkermansia in human diseases: from causation to therapeutic properties. Nutrients 15, 1815 (2023).
pubmed: 37111034
pmcid: 10142179
doi: 10.3390/nu15081815
Jensen, M. et al. Akkermansia muciniphila exoglycosidases target extended blood group antigens to generate ABO-universal blood. Nat. Microbiol. 9, 1176–1188 (2024).
pubmed: 38684911
doi: 10.1038/s41564-024-01663-4
Anso, I. et al. Turning universal O into rare Bombay type blood. Nat. Commun. 14, 1765 (2023).
pubmed: 36997505
pmcid: 10063614
doi: 10.1038/s41467-023-37324-z
Chua, H.-H. et al. Antagonism between gut Ruminococcus gnavus and Akkermansia muciniphila modulates the progression of chronic hepatitis B. Cell Mol. Gastroenterol. Hepatol. 17, 361–381 (2024).
pubmed: 38092311
doi: 10.1016/j.jcmgh.2023.12.003
Liu, Y.-F. et al. Astaxanthin alleviates chronic prostatitis/chronic pelvic pain syndrome by increasing colonization of Akkermansia muciniphila in the intestine. Phytomedicine 123, 155249 (2024).
pubmed: 38056144
doi: 10.1016/j.phymed.2023.155249
Qiao, C.-M. et al. Akkermansia muciniphila is beneficial to a mouse model of Parkinson’s disease, via alleviated neuroinflammation and promoted neurogenesis, with involvement of SCFAs. Brain Sci. 14, 238 (2024).
pubmed: 38539626
pmcid: 10968773
doi: 10.3390/brainsci14030238
Guo, H., Liu, X., Chen, T., Wang, X. & Zhang, X. Akkermansia muciniphila improves depressive-like symptoms by modulating the level of 5-HT neurotransmitters in the gut and brain of mice. Mol. Neurobiol. 61, 821–834 (2024).
pubmed: 37668965
doi: 10.1007/s12035-023-03602-6
Kim, J. Y. et al. Akkermansia muciniphila extracellular vesicles have a protective effect against hypertension. Hypertens. Res. 47, 1642–1653 (2024).
pubmed: 38503939
doi: 10.1038/s41440-024-01627-5
Ou, Z. et al. Protective effects of Akkermansia muciniphila on cognitive deficits and amyloid pathology in a mouse model of Alzheimer’s disease. Nutr. Diabetes 10, 12 (2020).
pubmed: 32321934
pmcid: 7176648
doi: 10.1038/s41387-020-0115-8
Ding, Y. et al. A next-generation probiotic: Akkermansia muciniphila ameliorates chronic stress-induced depressive-like behavior in mice by regulating gut microbiota and metabolites. Appl. Microbiol. Biotechnol. 105, 8411–8426 (2021).
pubmed: 34617139
doi: 10.1007/s00253-021-11622-2
DeSana, A. J., Estus, S., Barrett, T. A. & Saatman, K. E. Acute gastrointestinal permeability after traumatic brain injury in mice precedes a bloom in Akkermansia muciniphila supported by intestinal hypoxia. Sci. Rep. 14, 2990 (2024).
pubmed: 38316862
pmcid: 10844296
doi: 10.1038/s41598-024-53430-4
Hammer, T. J. Why do hosts malfunction without microbes? Missing benefits versus evolutionary addiction. Trends Microbiol. 32, 132–141 (2024).
pubmed: 37652785
doi: 10.1016/j.tim.2023.07.012
Kobayashi, Y., Kawahara, T., Inoue, S. & Kohda, N. Akkermansia biwaensis sp. nov., an anaerobic mucin-degrading bacterium isolated from human faeces. Int. J. Syst. Evol. Microbiol. 73, https://doi.org/10.1099/ijsem.0.005697 (2023).
Gilroy, R. et al. Extensive microbial diversity within the chicken gut microbiome revealed by metagenomics and culture. PeerJ 9, e10941 (2021).
pubmed: 33868800
pmcid: 8035907
doi: 10.7717/peerj.10941
Richter, M. & Rosselló-Móra, R. Shifting the genomic gold standard for the prokaryotic species definition. Proc. Natl Acad. Sci. USA 106, 19126–19131 (2009).
pubmed: 19855009
pmcid: 2776425
doi: 10.1073/pnas.0906412106
Becken, B. et al. Genotypic and phenotypic diversity among human isolates of Akkermansia muciniphila. mBio 12, 00478–21 (2021).
doi: 10.1128/mBio.00478-21